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ABSTRACT
Wilcox, Ashley M. M.S., Department of Chemistry, Wright State University, 2019.
Silver Nanoparticles: An effective antibacterial agent against Gram-negative
bacteria

A fourth of the world’s population lack access to safe water1, thus the need for a
more effective water treatment is imperative. Interest in silver nanoparticles
(AgNPs) has grown in the last decade2. Unlike chlorine, AgNPs do not form
disinfection by products (DBPs), making them a prime candidate for drinking
water treatment. The main aim of this study was to compare the antibacterial
activity of electrochemical silver nanoparticles (eAgNPs-f) of ~5 nm in diameter
against well-established pathogens: Escherichia coli (E. coli), Klebsiella variicola
(K. variicola), and Pseudomonas aeruginosa (P. aeruginosa) to chlorine and Ag+
for drinking water. This was achieved by determining the Minimum Inhibitory
Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of eAgNPs,
which were synthesized electrochemically and then concentrated (eAgNPs-f).
The MIC values for E. coli, K. variicola, and P. aeruginosa were 4 ± 3, 3 ± 2, and
3 ± 2 mg L-1, respectively. The MBC values for the same bacteria were 4 ± 3, 5 ±
2, and 5 ± 4 mg L-1, respectively. When tested against chlorine, the MIC and
MBC values increased over 1000-fold. CytoViva Hyperspectral Microscopy
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demonstrated the eAgNPs-f’s affinity for the cellular membrane of E. coli after 30
minutes and physical cellular damage after 1 hour. Membrane disruption was
confirmed through monitoring K+ leakage on ICP-OES. It was found that
eAgNPs-f have a rapid and time consistent effect on K+ leakage, when compared
to untreated control cells and Ag+. These results suggest that eAgNPs-f
containing Ag+ ions are a more effective antibacterial agent than Ag+ alone, or
chlorine.
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Introduction
In recent years, silver nanoparticles (AgNPs) have been growing in
popularity from ~192 consumer products containing nanomaterial in 2012 to
~380 products in 20192. AgNPs are commonly employed because of their unique
conductive, catalytic, optical, and most notably, their antibacterial properties,
when compared to bulk silver3. The Nanomaterial Registry instituted minimal
information about nanomaterials (MIAN) for physicochemical characteristics in
order to use it as a guideline for the organization and storage of nanomaterial
information4. The MIAN states that there are six PCCs that are independent of a
nanomaterial’s system: composition, purity, shape, size, size distribution, and
surface chemistry. The other six that are dependent on a nanomaterial’s system
are: aggregation/agglomeration state, solubility, stability, surface area, surface
charge, and surface reactivity4. Synthesizing AgNPs with various PCCs allows for
the optimization of antibacterial activity.
Worldwide approximately ~800 million people are without a basic-drinking
water service and another 2 billion people consume water contaminated with
feces1, making the need for water treatment imperative. Several commonly
accepted water sanitation methods are: ultraviolet irradiation, ozone, and
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chlorination. More effective than chlorine, ozone only requires 10-30 minutes of
contact time and is generated on site, which reduces safety issues5. However,
ozone requires more complex instrumentation, which increases price of
production, and produces carcinogenic disinfection byproducts (DBPs) such as
bromate, when used to treat water containing bromide5-6. Ultraviolet irradiation
does not require the generation or handling of chemicals and only requires 20-30
seconds of contact time when using low-pressure lamps. Nevertheless, some
organisms are able to repair themselves against UV damage and the turbidity of
wastewater can inhibit the overall effectiveness of this method7. Most commonly
used, chlorination is the most cost effective method on the market at $0.01 to
$0.05 per liter of water treated8. Chlorination provides a residual that prolongs
the disinfection, but proves toxic to aquatic life. Like ozone, chlorination produces
DBPs, such as trihalomethanes, chlorite, and chlorate9. Thus, the need for a
more cost effective and safe method of water sanitation has grown.
The U.S. Environmental Protection Agency (U.S. EPA) National Primary
Drinking Water Regulations are primary standards and treatment techniques for
public water systems that are enforceable by law10. For chlorine, the National
Primary Drinking Water regulation is 4 mg L-1. The U.S. EPA does not, however,
have any primary drinking guidelines for silver nanomaterials10. The EPA has
established Secondary Drinking Water Guidelines, which are in place for
contaminants that are not considered a health risk and are only tested for on a
voluntary basis11. If contaminants are present above the secondary guideline,
they can cause a cloudy or colored appearance to the water. Silver (Ag+) is
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considered a non-essential element for humans and has a Secondary Drinking
Water Guideline of 0.1 mg L-1 11. Above this level, discoloring of the skin, known
as argyria, can occur due to the indefinite absorption of Ag+ in tissues. According
to the World Health Organization, a dose of 10 g of silver nitrate would be lethal
to humans, but 0.6 to 0.9 g of silver may only cause argyria12.
Three pathogens of interest for this study are E. coli, K. variicola, and P.
aeruginosa. According to the U.S. EPA, total coliforms are tested most frequently
in water contamination13. Total coliforms consist of Escherichia coli, fecal
streptococci, and enterococci. Total coliforms are used as an indicator in drinking
water because this confirms contamination by an outside source. Klebsiella
variicola (K. variicola) and Escherichia coli (E. coli) are a part of fecal coliforms,
which is a subset of total coliforms. E. coli is found naturally in the
gastrointestinal tract of humans, however when found it other areas of the body,
it can cause urinary tract infections, diarrhea, abdominal cramps, nausea, and
headaches14. K. variicola naturally occur in water environments and the feces of
healthy humans and animals. Infection from K. variicola is most commonly
spread through hospitals and contaminated water14. Pseudomonas aeruginosa
(P. aeruginosa), while not a water indicator organism, is an environmental
pathogen that can be found in soil, water, and feces13. It can also cause
infections primarily on damaged sites, such as burns14. These pathogens are
prokaryotic, meaning they have no organelles. Thus, their cell membrane and
cell wall play many essential roles15. The cell membrane provides selective
permeability and the transport of solutes and it contains the enzymes and carrier
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molecules that function in the biosynthesis of DNA and membrane lipids15. The
cell wall, which is negatively charged (~-75 mV)16, plays an essential role in cell
division, and provides osmotic protection. The two classifications for bacteria are
Gram-negative and Gram-positive; the three previously above-mentioned
pathogens are Gram-negative (E. coli, K. variicola, and P. aeruginosa). The
difference lies in the composition of the cell wall. Gram-positive bacteria have a
much thicker peptidoglycan layer (~80 nm) than Gram-negative bacteria (~8 nm).
Gram-negative bacteria also have an outer membrane and periplasmic space.
The peptidoglycan layer consists of three parts: a backbone, a set of tetrapeptide
side chains, and a set of peptide cross-bridges15.
The antibacterial mechanism of AgNPs is still widely unknown 17. One
potential mechanism of action is cellular component leakage. In one study, E. coli
and S. aureus were exposed to Ag+ for 2 hours, after which transmission electron
microscopy (TEM) revealed that the cell wall had become detached from the
cellular environment and cellular components leaked out18. Thus, it was
hypothesized that the antibacterial properties are related to the release of Ag+
ions. Another study examined the effects of AgNPs on the intracellular potassium
content19. Thus, it is expected that the ruptured cell walls are the result of
exposure to AgNPs, which may cause an imbalance in the cell potential and
thereby trigger K+ leakage19.
Many studies indicate that silver’s ability to generate reactive oxygen
species (ROS) and its affinity for R-SH groups are antibacterial pathways. Ag+
can readily bind to –SH groups, such as on the amino acid, cysteine. Binding to
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cysteine can directly inhibit the function of different enzymes. ROS, such as
superoxides, free radicals, and peroxides occur when the cell undergoes
oxidative stress20; increased stress increases ROS. One method of destruction
from ROS comes from lipid oxidation associated with free radicals. Another
study17 in this review demonstrated that AgNPs produce more ROS than Ag+
alone.
The main objective of this study is to compare the antibacterial effects
of eAgNPs-f to chlorine and Ag+ for drinking water. This study will explore the
antibacterial effects and the mechanism of electrochemical colloidal silver
nanoparticles (eAgNPs) against three Gram-negative bacteria: E. coli, K.
variicola, and P. aeruginosa.
Specific Aim 1: To electrochemically fabricate, and characterize silver
nanoparticles. An electrochemical method of synthesis will be utilized via cathode
and anode. These nanoparticles will be characterized using several analytical
techniques, such as UV-Vis Absorption Spectroscopy, Inductively Coupled
Plasma-Optical Emission Spectroscopy (ICP-OES), and Raman Spectroscopy.
Specific Aim 2: To study the antibacterial effect of eAgNPs on
common water and environmental organisms (Escherichia coli, Klebsiella
variicola, and Pseudomonas aeruginosa) using Minimum Inhibitory Concentration
(MIC) and Minimum Bactericidal Concentration (MBC) assays.
Specific Aim 3: To investigate the antibacterial mechanism of action of eAgNPs.
This will be accomplished using CytoViva Hyperspectral Imaging and ICP-OES.
ICP-OES will be employed to determine the levels of K+ after exposure to
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eAgNPs at different time frames. CytoViva Hyperspectral Imaging will be used to
visualize the location and distribution of the eAgNPs on the exposed cell and will
hyperspectrally confirm their presence.
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Materials and Methods
Materials
All chemicals used in this study were purchased from Fischer Scientific and were
used without further modification. High quality water (≥ 18 MΩ • cm) and distilled
water were utilized as indicated below. OPTIMA grade nitric acid (HNO3) was
obtained for trace metal analysis on ICP-OES. Escherichia coli, Klebsiella
variicola, and Pseudomonas aeruginosa were purchased from ATCC (ATCC®
25922TM, ATCC® 31488TM, and ATCC® 27853TM, respectively).
Synthesis of colloidal, electrochemical silver nanoparticles (eAgNPs)
Silver nanoparticles were synthesized according to an electrochemical method
modified in our lab (Figure 1)21-22. Briefly, two 0.635 cm x 0.33 cm flat silver
electrodes (SilverGen Model SG6 Auto, WA, USA) were placed in a lab jar filled
with 850 mL of distilled water (average pH.8.25) and a concentration of ~15
mg L-1 was achieved after constant electric current of 30 mA was applied. The
resulting colloid was filtered through a 0.45 µm nitrocellulose membrane filter
(Fisher Scientific). Five hundred milliliters of the filtered colloid were then
evaporated down to ~ 25 mL on a hot plate at 275 °C (eAgNPs-f).
Characterization of eAgNPs-f
UV-Vis absorption spectroscopy of eAgNPs-f
The absorption measurements were carried out in a disposable cuvette (1 cm
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optical path) using a Varian Cary Bio 50 spectrophotometer. A fast scan rate was
employed from 200 nm to 800 nm, with baseline correction. Data was processed
using Origin 8 software.
Inductively coupled plasma-optical emission spectroscopy (ICP-OES) of
eAgNPs-f
Colloidal samples were cold digested by mixing 3 mL of HNO3 (67-70%) with 10
µL of each sample for 10 minutes at room temperature. This was followed by
heating at 275 ºC until ~10 µL of the mixture remained. The digested samples
were then diluted to 10 mL with 286 µL of HNO3 and high quality water for a final
concentration of 2% HNO3 in 10 mL volumetric flasks. The samples were then
analyzed on a Varian 710 ICP-OES equipped with a SPS 3 autosampler, at a
pump rate of 2 mL min-1. A triplicate read time of 15 s and a sample uptake time
of 40 s were employed. An external calibration method was established using 10
standards (0-700 µg L-1) by dilutions with 2% HNO3 from a Ag+ stock (1000
mg L-1, SPEX CertiPrep). The two most intense emission wavelengths of Ag
(328.068 nm and 338.289 nm) were used for analysis. The Ag+ concentrations
were determined by interpolation from the calibration curve in Origin 8 software
(Figure S1).
Zeta Potential of eAgNPs-f
First, a quality control standard of -68.0 ± 6.8 mV was measured on a Zetasizer
Nanoseries (Malvern Instruments). Samples of 0.75 mL were then analyzed
using the default method. Readings for mV, from -150 to +150 mV, and
intensities (N = 80) were collected. The reading with the highest intensity was
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taken as the zeta potential21 .
Raman Spectroscopy of eAgNPs-f
Colloids were placed in 2 mL quartz cuvettes and their Raman spectra were
collected using a LabRam HR-800 (Horiba Jobin Yvon, Inc.) system equipped
with an internal HeNe laser beam (632.8 nm, 15 mW output) of a spot diameter
of ~1 µm. A Raman BX41 microscope with an Olympus objective (50x) was used
in conjunction with a confocal hole of 300 µm. A cooled CCD detector (1024 Å x
256 pixels) was employed for the data collection in the range of 100-400 cm-1,
with ~1 cm-1 spectral resolution (3 cycles and 30 s acquisition times). The Raman
spectra were collected in the LabSpec v.5 and analyzed in Origin 8 software 21.
Transmission Electron Microscopy (TEM) of eAgNPs-f
Colloidal samples were deposited onto 200 hex mesh formvar-coated copper
grids (Electron Microscopy Sciences, FF200H-Cu). The samples were then
allowed to dry in a desiccator, at room temperature overnight, before analysis in
a TEM system (Phillips EM 2085, 70 kV) equipped with a Gaton Bioscan camera.
Analysis of particle size was conducted in ImageJ 1.50e software based on the
Dune Scientific’s procedure 23-24. Average size and distribution were determined
from N = 500 eAgNPs-f in JMP software21.
CytoViva Hyperspectral Microscopy of eAgNPs-f
Five microliters of colloid were deposited onto a glass microscope slide, covered
with a glass microscope slip, allowed to dry for 15-20 minutes, and subsequently
sealed with clear nail polish. A CytoViva enhanced darkfield microscope
(Olympus BX53) equipped with a 50 W halogen light source and a VNIR
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spectrophotometer (400-1000 nm) was employed for sample imaging (10x Air
objective, 60x, and 100x oil immersion objective). Hyperspectral data (N = 150)
was collected using the ENVI 4.8 software. A full scan was employed (696 lines,
696 x 696 pixels) with exposure times varying from 0.25 s to 1.0 s, using the 60x
or 100x oil objectives. Data was analyzed using Origin 8 software.
Growth of bacteria
Single colonies, which were recovered from stock cultures, were added to ~5 mL
of tryptic soy broth (TSB, BD BactoTM Tryptic Soy Broth, LOT 4232501) in
disposable test tubes (Fisher Scientific FalconTM Polystyrene Round-Bottom
Tube) and incubated for 24 hours at 37 ºC. Bacteria were plated on agar plates,
which were prepared in advance by dispensing 15 mL of autoclaved agar/nutrient
broth solution into petri dishes (Fisherbrand, 100 mm x 15 mm, Sterile,
Polystyrene). The plates were again incubated for 24 hours at 37 ºC. The
following day, four colonies of similar size were added to ~5 mL of TSB to
continue the cycle.
Characterization of bacteria
CytoViva Hyperspectral Microscopy of bacteria
Five microliters of diluted bacterial suspension were deposited on a glass
microscope slide, covered with a microscope glass slip, allowed to dry for 15-20
minutes, and then sealed with clear nail polish. CytoViva data collection was
similar to that described above for eAgNPs.
Antibacterial Studies of eAgNPs-f
Bacterial Growth
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For continued growth, the bacteria were adjusted to an OD600 value of 0.2 using
UV-Vis absorption spectroscopy (0.08-0.13 a.u.). One hundred microliters of the
0.2 OD bacteria were added to 9.9 mL of Mueller Hinton Broth (MHB, Fisher
Scientific, BD BBLTM, Cation Adjusted, LOT 8096574). Next, 10 µL from that
dilution were mixed with 990 µL of MHB in a microfuge tube and 100 µL of the
resulting solution were combined with 900 µL of MHB in another microfuge tube.
From each dilution, 100 µL were plated on nutrient agar plates (Fisher
BioReagents, LOT 133220, Fisher Scientific DifcoTM Nutrient Broth, LOT
4251990), which were prepared in advance by dispensing 15 mL of autoclaved
agar/nutrient broth solution into petri dishes (Fisherbrand, 100 mm x 15 mm,
Sterile, Polystyrene). The plates were again incubated for 24 hours at 37 ºC and
the number of colonies was visually counted for quality control.
Minimum Inhibitory Concentration (MIC)
A broth micro-dilution method with overnight bacterial cultures was used to
determine the MIC 25. Briefly, a 96-well microtiter plate (Figure S2) with a final
well volume of 200 µL containing various volumes of MHB, various volumes of
eAgNPs-f, Ag+ or chlorine, and 100 µL of bacteria (final cell density of 1 x 105
CFU mL-1) were incubated for 24 hours at 37 ºC. The OD600 values for all bacteria
were adjusted to 0.2 OD (0.08-0.13 a.u.) using UV-Vis absorption
spectroscopy26.
Minimum Bactericidal Concentration (MBC)
One hundred microliters from the MIC wells that did not exhibit growth were
plated on nutrient agar plates. The plates were incubated for 24 hours at 37 ºC
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and the MBC was determined as the lowest concentration with less than 10
colonies25. MIC and MBC data were processed in Excel, Origin 8, and JMP
software.
Free chlorine and total chlorine concentrations
The N,N-diethyl-p-phenylenediamine (DPD) colorimetric method was employed
to determine the free chlorine and total chlorine concentrations using the HACH
DPD reagent and a pocket colorimetric analysis system (HACH, USA).
Antibacterial pathway studies for eAgNP-f
CytoViva Hyperspectral Imaging
Briefly, 50 µL of bacteria (0.2 OD), 50 µL of MHB, and 100 µL of eAgNP-f were
combined for a final concentration of 10 mg L-1 of eAgNPs. The mixture was
incubated for 24 hours before processing on CytoViva. Five microliters of the
previously treated bacteria were placed on a glass microscope slide, covered
with a glass cover slip, allowed to dry for 15-20 minutes, and sealed with clear
nail polish. CytoViva data collection was similar to that described above for
eAgNPs.
Potassium (K+) Flux Experiments
The potassium flux experiments were conducted according to a modified Iscla et
al. method27. Cultures were grown overnight from a single colony in TSB and
were adjusted to OD600 of ~0.3 to 0.5 and split into disposable centrifuge tubes
(Corning, 430829). One tube contained the test agent, while the other was run
with media and bacteria (negative control). The test agents included Ag+ and
eAgNPs-f. Each tube was incubated at MIC concentration for 0,1, 2, 4, 24 hours
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at 37 ºC. Aliquots from the culture tube were taken for OD600 readings and
potassium analysis (~2 mL, and 5 mL, respectively). OD600 values were
measured by an absorption spectrometer (Spectronic 20D, Thermo Fisher
Scientific). The K+ sample was put through a 0.45 µm nitrocellulose membrane
filter and washed with ~15 mL of K0 minimal media containing no potassium (46
mM Na2HPO4, 23 mM NaH2PO4, 0.5 g NaCl, and 1 g NH4Cl). The filters were
placed in beakers, covered with foil, and dried at 80 ºC, overnight. High quality
water (10 mL) was filtered in and then transferred to a disposable test tube,
where 286 µL of 70% HNO3 were added to make a 2% HNO3 solution. The
samples were analyzed on ICP-OES (Varian 710-ES) to determine K+ levels.
Inductively Coupled Plasma-Optical Emission Spectroscopy (ICP-OES) for
K+
The potassium samples were run on a Varian 710-ES using an autosampler
(Varian SPS 3). Briefly, samples were nebulized at a pressure of 200 kPa and
pumped at a rate of 2 mL min-1 to the quartz torch. Two main emissions of K
(766.491 and 769.897 nm) were analyzed at a plasma flow of 15.0 L min-1, an
auxiliary flow of 1.5 L min-1, a radio-frequency power of 1.20 kW, a replicate read
time of 15 s, an internal stabilization delay of 45 s, a sample uptake delay of 40 s,
and a rinse time of 15 s. Ten working K+ standards (0-5 mg L-1) were created
from a stock K+ standard (1000 mg L-1, SPEX CertiPrep) using serial dilutions in
2% HNO3 in order to plot an external calibration curve using the emission
intensity of the standards as a function of the K+ concentrations. The total
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concentration of K+ in each sample was determined by interpolation from this
curve (Figure S3).
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Results & Discussion
Synthesis of eAgNPs
Silver nanoparticles were synthesized via an electrochemical process involving
the oxidative dissolution of a sacrificial silver anode in a distilled water bath of a
commercially available SilverGen system (Figure 1). An electric current was
created as Ag+ migrated toward the cathode, where the reduction of Ag+ to Ag0
occurred. This was followed by the nucleation and growth of Ag0 into AgNPs via
van der Waals forces, which was further promoted by mechanical spinning.
Electrostatic stabilization of AgNPs is probably accomplished through capping
with hydroxide ions (OH-) generated during water electrolysis. The hydroxide
capping probably occurred through the adsorption of OH- ions onto the surface of
the eAgNPs28. Simultaneously, the electrolysis of water at the anode produces
oxygen gas. Meanwhile, hydrogen ions collect at the cathode and produce
hydrogen gas and hydroxide ions. Some of the Ag+ ions from the anode may
combine with the OH- ions to form AgOH, which spontaneously decomposes to
Ag2O. Finally, some of the Ag0 adheres to the cathode22.
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Figure 1. Depiction of the mechanism behind the electrochemical synthesis of
AgNPs in a SilverGen system.
Characterization of eAgNPs-f
The formation of eAgNPs-f was confirmed by the light-yellow coloration of the
final colloid (Figure 2a inset) and the presence of a surface plasmon resonance
peak (SPRP) at 426 nm (Figure 2a). The purity of the eAgNP final colloid was
established through Raman spectroscopy (Figure 2b). Briefly, only the three
characteristic vibrational modes of water associated with the –OH bending and
stretching were detected at 1667, 3231, and 3404 cm-1, respectively. The
CytoViva darkfield image was used to retrieve the hyperspectral signatures of
each eAgNP-f size (Figure 2c and 2d): ~60% of eAgNPs-f were color-coded in
blue (475 nm), ~27% in green (549 nm), and ~13% in red (624 nm). eAgNPs-f (N
= 1982) were also visualized by TEM (Figure 2e) and the resulting images were
analyzed to determine their corresponding mean diameter of 5 ± 4 nm (Figure
2f). The TEM image of eAgNP-f showed low aggregation with narrow distribution
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(1-45 nm). The average (N = 23) zeta potential for the final colloid was
determined to be -22 ± 14 mV.

Figure 2. eAgNP-f characterization: 2a. UV-Vis absorption spectrum displaying
the surface plasmon resonance peak (SPRP), 2b. Raman spectrum exhibiting
the characteristic vibrational modes of water, 2c. CytoViva darkfield image
showing the three color-coded eAgNPs (blue, green, and red), 2d. Averaged (N =
50) CytoViva hyperspectral signatures for each eAgNP-f size (similarly colorcoded), 2e. TEM image illustrating the size distribution and the aggregation state,
and 2f. TEM size histogram showing the distribution of sizes (N = 1982).
Antibacterial Studies of eAgNPs
The minimum inhibitory concentration (MIC) is the lowest concentration of test
agent required to inhibit visible growth, while the minimum bactericidal
concentration (MBC) is the lowest concentration needed to reduce 99.9% of the
microorganisms29. A microorganism’s resistance and in vitro bacteriostatic
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activity is confirmed using MICs29 . In order to be considered bactericidal, the
MBC of the test agent has to be less than four times the value of the MIC30. In
this antibacterial study, the MIC and MBC values were established at the
recommended final inoculum density 25 of 1 x 105 CFU mL-1 against the most
well-established water indicator organism (E. coli), a fecal contamination
representative (K. variicola), and a common, opportunistic organism (P.
aeruginosa)13. E. coli: The average MICs for eAgNP-f, chlorine and Ag+ were 4 ±
3, 2000 ± 3000, and 3 ± 2 mg L-1, respectively. The average MBCs were
determined as 4 ± 3, 3000 ± 3000, and 3 ± 4 mg L-1. K. variicola: The average
MICs were 3 ± 2, 4000 ± 3000, 4 ± 2 mg L-1; while the average MBCs were 5 ± 2,
4000 ± 3000, and 5 ± 2 mg L-1. P. aeruginosa: The average MICs for were 3 ± 2,
5000 ± 3000, and 3 ± 1 mg L-1; while the average MBCs were 5 ± 4, 5000 ±
3000, and 5 ± 2 mg L-1 (Figure 3). Actual MIC and MBC values together with the
corresponding standard deviations can be found in Table S1. These MIC and
MBC results demonstrate that each test agent exhibits bactericidal activity.
However, the MIC and MBC values for chlorine were ~1000-fold greater than
those of eAgNPs-f and Ag+. A one-way ANOVA post-hoc Tuckey HSD test
confirmed the statistical difference (P < 0.0001) between chlorine and the two Ag
(eAgNP-f and Ag+) species. Furthermore, there was no statistically significant
difference between eAgNP-f and Ag+ (P > 0.05). This might be explained by the
high Ag+ content (~60%) of eAgNPs-f. Thus, the Ag+ ionic component may play
an essential role in the toxicity of the eAgNPs-f and its interaction with the cell
membrane. The eAgNPs-f that interact with the cell may produce a central
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source of ions allowing further damage to the cell membrane and causing higher
toxicity17. In our previous studies21, tangential flow filtration was applied to the
original colloid in order to isolate, concentrate, and purify the eAgNPs-f from Ag+
ions present within this colloid. Further experiments on the eAgNPs alone (no
Ag+ ions) showed that there was no statistical significance (P > 0.05) between
the MICs and MBCs of these two Ag species of the original colloid21. These
results suggest that both components of the eAgNP-f colloid (nano Ag and Ag+)
are determining antibacterial factors of relatively equal strength.
The bacterial activity at 0.1 mg L-1 of eAgNP-f and Ag+ was investigated
for E. coli, K. variicola, and P. aeruginosa (Figure 4, Table S2). A study31
conducted in Isiolo County, Kenya determined the average total coliforms of
surface water (river, spring, rain, and pan)was ~2200 CFU mL-1. More
specifically, the average E. coli found was 42.95, 35.92, 160.0, and 6.25 FU mL1

, respectively 31. In our study, both eAgNPs-f and Ag+ inhibited over 3,000 CFU

mL-1 of E. coli, drastically surpassing the average microbial counts for this
Kenyan county. Over 8,000 CFU mL-1 of K. variicola and ~2,000 CFU mL-1 of P.
aeruginosa were also inhibited by eAgNPs-f. Ag+ inhibited the largest amount of
K. variicola, ~20,000 CFU mL-1, and only ~1,100 CFU mL-1 of P. aeruginosa.
Both eAgNP-f and Ag+ from our study were effective in inhibiting much larger
bacteria populations than those identified in the water pollution study of Kenyan
surface water described above31.
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Figure 3. MIC (3a) and MBC (3b) values for eAgNP-f, Ag+, and chlorine against
E. coli, K. variicola, and P. aeruginosa. Values were statistically different (P <
0.0001) for eAgNP-f, Ag+, and chlorine, while no difference (P > 0.05) was found
for eAgNP-f and Ag+. Note there are two y-scales.

Figure 4. Bacteria inhibited (CFU mL-1) at a dose of 0.1 mg L-1 of eAgNP-f or
Ag+.
Antibacterial pathway of eAgNP-f
CytoViva hyperspectral microscopy was employed to visualize a control
suspension of E. coli undergoing cell elongation characteristic to bacterial binary
fission (Figure S2). Cells were then imaged after incubation with 25 mg L-1 of
eAgNPs-f to monitor their physical interaction as a function of time (0, 30, and 60
minutes and 24 hours). Initially (Figure 5a-5c), eAgNP-f and E. coli were visible
with little or no interaction occurring. After 30 minutes (Figure 5d), eAgNPs-f were
observed attaching to the membrane of the cell. After 60 minutes (Figure 5e),
physical damage to the cellular membrane started to be noticeable. The
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hyperspectral signatures collected at these incubation times displayed a red shift
in the characteristic peak of eAgNPs as a result of their interaction with the
cellular matrix (Figure 5f). After 24 hours (Figure 5g and 5h), complete disruption
of the cell membrane was noticed, with cellular components leaking out (Figure
5g and 5h). Blue and green color-coded eAgNPs red-shifted by 24-105 nm after
24 hours of incubation and had an average peak maximum at 573-580 nm
(Figure 5i). The red color-coded eAgNPs blue-shifted by 16 nm after 24 hours
and had a peak maximum at 609 nm. These signatures emerging after the cell
incubation with eAgNPs-f were a combination of hyperspectral contributions from
both eAgNPs-f and cells. Thus, the observed broadening of the eAgNPs-f peaks
was the result of their interaction with E. coli cells; the full width at half maximum
(FWHM) increased by ~45 nm and ~95 nm for the green and red, and blue colorcoded eAgNPs-f, respectively after cellular interaction. An additional peak
emerged at ~800 nm after E. coli were treated with eAgNPs-f. The CytoViva
darkfield images suggested this might be due to the leaking of membrane
components, which appeared intense red (Figure 5g). The experiments
conducted over 0, 30, and 60 minutes, and 24 hours demonstrated the physical
attachment of eAgNPs-f to the cell membrane after just 30 minutes and their
internalization by 24 hours.
AgNPs are known to form biomolecular coronas when dispersed in
biological medium due to their high surface free energy (Figure 6)32. After 1 hour
of incubation with MHB, the eAgNPs-f SPRP at 416 nm experienced ~20 nm
broadening of the FWHM, probably due to the interactions with the broth
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components such as casein hydrolysate, which is the primary component of
MHB. As a result, cell membrane receptors may have prompted recognition and
subsequent uptake of eAgNPs-f32 (Figure 7b). However, the majority of eAgNPs-f
were observed at the cell membrane level after the 60 minutes exposure (Figure
5). This accumulation of eAgNPs-f (-22 ± 14 mV) at the cell membrane (~ -75
mV)16 occurred in spite of their repulsive negative charges. As it was observed in
previous Raman and Surface Enhanced Raman Spectroscopy (SERS) studies 34,
this interaction might be due to the formation of direct covalent bonds between
eAgNPs and cell membrane components of high affinity toward Ag. More
specifically, eAgNPs-f may form Ag-O covalent bonds with the
lipopolysaccharides within the outer and inner cell membranes35. Direct cellular
attachment of eAgNPs-f may also occur through the formation of covalent Ag-O
and Ag-N bonds in the peptidoglycan layer (Figure 7a). In addition, strong
electrostatic interactions may occur between the negatively charged
lipopolysaccharide coating and the Ag+ ions present within the eAgNP-f colloid or
released by the eAgNPs-f within the biological matrix (Figure 7a). Furthermore,
Gram-negative bacteria also have a thin peptidoglycan layer (~8 nm), which may
enable these Ag+ ions to enter cells more easily than the Gram-positive bacteria
of a thicker peptidoglycan layer (~80 nm)17. Thus, it is believed that Ag in both
nano and ionic form strongly interact with bacteria cells, particularly the
membrane and thereby impede cell growth and cause cell membrane damage
and subsequent potassium leakage36, protein denaturation17, DNA damage17,
and enzyme inactivation through ROS17 (Figure 7b).
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Figure 5. CytoViva Hyperspectral Imaging characterization of E. coli: 5a.
Darkfield image displaying t0 of eAgNP-f and E. coli, 5b. Darkfield image
displaying interaction of eAgNP-f and E. coli at t0, 5c. Averaged (N = 9) CytoViva
hyperspectral signature from eAgNP-f on the cell, 5d. Darkfield image of E. coli
after 30 minutes with 25 mg L-1 of eAgNPs-f indicating the interaction between
the two, 5e. Darkfield image of E. coli after 60 minutes with 25 mg L-1 of eAgNPsf indicating the beginning of physical disruption, 5f. Averaged (N = 6, and 11)
CytoViva hyperspectral signatures demonstrating the cellular interaction with
eAgNPs-f after 30- and 60 minutes, respectively, 5g. Darkfield image of E. coli
after 24 hours with 25 mg L-1 of eAgNPs-f demonstrating the disruption of the
cellular membrane, 5h. Darkfield image of E. coli after 24 hours with 25 mg L-1 of
eAgNPs-f exhibiting cell lysis with nanoparticles around the membrane and 5i.
Averaged Hyperspectral data corresponding to the color-coded signatures of
eAgNP-f.
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Figure 6. eAgNPs-f were incubated for 1 hr at 37°C with MHB and the resulting
spectra were obtained for control eAgNP-f, control MHB, and eAgNP-f + MHB.
Both colloidal eAgNP-f and eAgNP-f + MHB demonstrated a SPRP at 416 nm,
but post-incubation eAgNP-f experienced a broadening of ~20 nm of the FWHM
probably due to the interactions with broth components.

24

Figure 7. eAgNPs-f potential mechanisms of antibacterial activity 7a. Gramnegative cellular membrane composed of an outer membrane with a
lipopolysaccharide coating, a peptidoglycan layer, and the inner cell membrane
7b. Whole cell demonstrating different antibacterial pathways. Figure constructed
courtesy of Servier Medical Art
Potassium Leakage and Turbidity of E. coli
Potassium concentration plays a large role in prokaryotic cells. Potassium is an
osmotic solute, which helps maintain the integrity of the cellular membrane and
activates intracellular enzymes37. E. coli has a variety of pathways to regulate
intracellular K+ concentrations. In this study, potassium leakage was monitored
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after 0, 1, 2, 4, and 24 hours incubation with eAgNPs-f. OD600 measurements
were also conducted to track the growth of E. coli by turbidity within the same
time frames. The OD600 values for untreated E. coli (i.e. E. coli and MHB)
increased nonlinearly over 24 hours indicating a healthy bacterial growth, with an
initial average reading of 0.16 ± 0.04 a.u. and a final average reading of 0.8 ± 0.1
a.u. (Figure 8a). Statistical analysis of the values revealed that each OD600
control value was statistically different than the initial control value (0 hours), with
P values ranging from P < 0.0001 to P = 0.0009. For E. coli treated with 4.10 mg
L-1 of eAgNPs-f (i.e., MIC value), the initial OD600 was 0.19 ± 0.07 a.u. After one
hour, the OD600 decreased by ~20% to 0.15 ± 0.08 a.u. suggesting a significant
inhibition in cell growth (P < 0.05). After 24 hours, the OD600 only reached 0.3 ±
0.1 a.u. (P < 0.05), which is less than ~50% of the OD600 value of the control cells
(Figure 8b). This small cell growth observed after 24 hours of eAgNP-f exposure
is probably due to the initial cell density, which is larger than the MIC cell density
that would be entirely inhibited by this amount of eAgNP-f test agent. It should be
noted that potassium leakage measurements could not be carried out at the cell
density corresponding to MIC values (4.1 ± 2.6 mg L-1) due to the limit of
detection of potassium in the ICP-OES method (0.075 mg L-1). However, none of
the 1, 2, 4, and 24-hour exposure to eAgNPs-f were statistically different from
each other (P > 0.05), which suggests rapid and time consistent bactericidal
effects for these nanomaterials. In contrast, the Ag+ reference took longer (4
hours) to significantly impede the cellular growth; more specifically, the OD600
value decreased to 0.27 ± 0.05 a.u. (P < 0.05) when compared to the
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corresponding control at 4 hours, 0.48 ± 0.04 a.u. Afterward (Figure 8c), the
OD600 values increased again to 0.8 ± 0.2 a.u. after 24 hours of Ag+ exposure,
which is not statistically different than the untreated cells, but is ~40% larger than
the corresponding OD600 value for eAgNPs-f at 24 hours (P < 0.05). These
results suggest eAgNPs-f containing Ag+ are a more potent and rapid growth
inhibitor than Ag+ alone.
The Na+ K+ pump is an active transport process, which transports Na+ out
of the cell and K+ into the cell through Na+ K+ ATPase (Figure S3). The binding of
eAgNP-f on the cellular membrane causes a depolarization, which in turn may
disrupt the Na+ K+ pump and cause ion leakage38. In this study, the amount of
potassium remaining in E. coli was monitored over the course of 24 hours under
the same exposure conditions. As the population of control cells grew over this
time period (Figure 9a), a nonlinear increase in K+ level was observed from 0.91
± 0.06 mg L-1 to 2.8 ± 0.2 mg L-1 (P < 0.001). No statistically significant (P > 0.05)
change was observed in the eAgNP-f exposure group within the first 4 hours
(Figure 9b). However, eAgNP-f caused drastic instantaneous changes in the K+
level when compared to the control untreated cells (P < 0.001). More specifically,
there was a ~85% decrease to 0.14 ± 0.06 mg L-1 at 0 hours. After 24 hours of
eAgNP-f incubation, the population of healthy cells grew and thus increased to
~30% of the control K+ levels to 0.9 ± 0.7 mg L-1 (P < 0.001). It should be noted
again that the K+ concentration experiments were carried out at a cell density
higher than that corresponding to MIC values. These changes in K+ levels upon
eAgNP-f exposure demonstrate the severe cell membrane disruption and
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subsequent K+ ion leakage. This is in good agreement with the above presented
CytoViva darkfield images (Figure 5), which revealed major physical damage at
the membrane sites surrounded by eAgNPs-f. It should be noted that at 2 and 4
hours, the K+ concentration fell below the limit of quantification (0.075 mg L-1) for
the instrument. While the precise values could not be calculated, the trend
remains the same. Ag+ also lead to decreases in K+ level at all times except for
24 hours (2.2 ± 0.2 mg L-1), when compared to the control cells (P < 0.001)
(Figure 9c). However, these K+ losses resulting from Ag+ exposure were not as
large as those caused by eAgNPs-f treatment. In fact, the smallest K+
concentration discrepancy in between the Ag+ and eAgNP-f exposures was
~17% after 1 hour incubation (P < 0.001), while the largest one was over 90% at
both 2 and 4 hours (P < 0.001). Overall, the cell measurements of internal K+
levels and growth results exhibited similar trends. This suggests that eAgNP-f
containing Ag+ are a more effective antibacterial agent than Ag+ alone within the
24-hour time frame.
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Figure 8. E. coli OD600 values at 0, 1, 2, 4, and 24 hours: 8a. Untreated E. coli
significantly increased after 24 hours (P < 0.001), 8b. E. coli exposed to 4.10 mg
L-1 of eAgNPs-f was significantly lower than the untreated bacteria at incubation
times 1, 2, 4, and 24 hours (P < 0.05), and 8c. E. coli exposed to 3.07 mg L-1 of
Ag+ were significantly different after 4 hours (P < 0.05) when compared to the
control cells. P values are provided for each control and exposure in Table S3.
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Figure 9. Potassium concentration remaining in E. coli after 0, 1, 2, 4, and 24
hours 9a. Untreated cells had a significant increase in K+ after 24 hours
(P<.0001) 9b. E. coli exposed to 4.10 mg -1 eAgNP-f had a significant decrease
in K+ over the first 4 hours (P < 0.0001) and was significantly lower after 24 hours
when compared to the untreated (P < 0.0001) and 9c. E. coli exposed to 3.07 mg
L-1 Ag+ differed significantly from the untreated for the first 4 hours (P < 0.0001).
P values can be found in Table S4.
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Conclusions
This study aimed to determine the antibacterial activity of electrochemical,
silver nanoparticles (eAgNP) of ~5 nm in diameter against well-established
pathogens: Escherichia coli (E. coli), Klebsiella variicola (K. variicola), and
Pseudomonas aeruginosa (P. aeruginosa) and to understand the mechanism
behind this activity. Silver nanoparticles were synthesized electrochemically and
concentrated via thermal evaporation in order to obtain ~5 nm spherical
nanoparticles. The Minimum Inhibitory Concentration (MIC) and Minimum
Bactericidal Concentration (MBC) of eAgNPs-f were determined. It was found
that eAgNP-f and Ag+ differ statistically from chlorine, having MICs and MBCs
ranging from ~3 mg L-1 to ~5000 mg L-1; MIC/MBC values for chlorine were
~1000-fold larger. However, eAgNP-f and Ag+ effects were not statistically
different and probably equally contributed to this antibacterial activity. This can
be attributed to the composition of the eAgNPs-f, which was found to be ~60%
ionic silver.
Bacterial activity at the EPA’s secondary drinking guideline limit for Ag+,
0.1 mg L-1, was also examined. Previous studies31 found there was an average of
~2200 CFU mL-1 in rivers, springs, rain, and pan water of a county in Kenya.
eAgNP-f and Ag+ inhibited ~3000 CFU mL-1 of E. coli. Over 8,000 CFU mL-1 of K.
variicola and ~2,000 CFU mL-1 of P. aeruginosa were also inhibited by eAgNPs-f.
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Ag+ inhibited the largest amount of K. variicola, ~20,000 CFU mL-1, but only
~1,100 CFU mL-1 of P. aeruginosa. Thus, both eAgNP-f and Ag+ may effectively
impede bacteria growth in such polluted surface waters.
In order to determine the cause of the eAgNPs-f antibacterial activity,
CytoViva was employed after a timed incubation of 0, 30, and 60 minutes and 24
hours. The darkfield images revealed eAgNP-f and cellular interaction
immediately. The eAgNPs-f were found around the membrane after 30 minutes
and by 60 minutes physical cell damage occurred. After 24 hours, cell
membranes were disrupted. Hyperspectral data revealed a red shift in the
absorbance peak of the blue and green color-coded eAgNPs-f, indicating the
interaction with the cellular matrix. This rapid interaction may be due to the
formation of a biomolecular corona around the eAgNPs-f. UV-Vis absorption
spectroscopy measurements of eAgNPs-f incubated with MHB suggest the
formation of a protein corona through the substantial broadening of their SPR
peak.
ICP-OES was employed to confirm the cell membrane disruption observed
in the darkfield images. K+ concentration and turbidity (OD600) were monitored in
E. coli over 24 hours of exposure to eAgNPs-f and Ag+ at MIC values. In
untreated control cells, the OD600 increased nonlinearly over 24 hours, indicating
healthy cell growth. Cells exposed to eAgNPs-f experienced a significant drop in
OD600 immediately after exposure. After 24 hours, the OD600 did not statistically
change from the initial value. However, it was found that the OD600 values for
eAgNPs-f were statistically different from the untreated cells at all time points.
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Ag+ imposed a less drastic effect immediately, as well. The result was consistent
after 4 hours; however, after 24 hours, the E. coli were able to recover to the
OD600 value of untreated cells. These results suggest eAgNPs-f containing Ag+
are a more potent and rapid growth inhibitor than Ag+ alone. The K+
concentration remaining in E. coli was measured on ICP-OES. The trends
exhibited were similar to that of the OD600 values. Untreated cells had higher K+
concentration at each time point, which suggests cell growth. Again, eAgNPs-f
demonstrated an immediate drop in the K+ concentration. During the 2 and 4
hours incubation, the concentration dropped below the limit of quantification
(0.075 mg L-1) for the instrument. But after 24 hours, the concentration was
statistically lower than the untreated cells. Ag+ again exhibited a similar trend, but
after 24 hours the K+ concentration was not statistically different than that of the
untreated cells.
The main aim of this study was to examine the antibacterial effects of
eAgNPs-f in order to investigate their application for drinking water treatment.
The MICs and MBCs demonstrated that the eAgNPs-f are over a ~1000-fold
more effective than chlorine. When examining the mechanism of eAgNPs-f,
monitoring K+ concentration demonstrated the statistical difference between the
nano and ionic forms of silver. These results suggest that eAgNP-f containing
Ag+ are a more effective antibacterial agent than Ag+ alone within the 24-hour
time frame.
Future experiments should be performed to confirm the presence of the
Ag-O bond that is hypothesized to occur in the interaction between eAgNPs-f and
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cell membrane components. CytoViva Hyperspectral imaging and K+
concentration monitoring should also be conducted on the other two pathogens
in order to further validate the proposed antibacterial mechanism in Gramnegative organisms. Lastly, ROS assays should be conducted to confirm the
formation of reactive oxygen species (ROS).
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Supporting Information

Figure S1. Silver ICP-OES calibration curve ranging from 0 to 700 µg L-1

Figure S2. MIC 96-well microtiter plate example

Figure S3. Potassium ICP-OES calibration curve ranging from 0 to 5 mg L-1
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Figure S4. CytoViva Hyperspectral Characterization for E. coli S2a. Darkfield
image of a control suspension of E. coli demonstrating healthy bacterial cell
fission, and S2b. Average (N = 50 data points) hyperspectral signature at 579 nm
for E. coli
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Table S1. MIC and MBC for eAgNP-f, Chlorine, and Ag+ as determined by
microdilution broth method for E. coli, K. variicola, and P. aeruginosa.
Bacteria
N

-1

MIC (mg L ) Std Dev

eAgNP-f
N
MBC (mg L-1)

Std Dev

E. coli

49

4.1

2.62

31

3.92

2.9

K. variicola

54

3.17

1.85

24

4.91

2.48

P. aeruginosa

46

3.11

2.31

22

4.99

4.22

-1

N

MIC (mg L )

E. coli

8

2068

K. variicola

9

3696

P. aeruginosa

8

4944

N

MIC (mg L-1)

E. coli

33

3.07

K. variicola

27

4.08

P. aeruginosa

24

3.26

Chlorine
Std Dev N MBC (mg L-1)
5
3300
2876
8
4161
3427
8
4944
3039
+
Ag
Std Dev
1.65
2.04
1.46

N MBC (mg L-1)

Std Dev
3069
3346
3039

Std Dev

21

3.47

3.53

17

5.39

2.35

13

4.56

2.17

Table S2. CFU mL-1 of bacteria inhibited at a 0.1 mg L-1 dose of eAgNP-f or Ag+
at 37°C for 24 hours
Bacteria

N

E. coli
K. variicola
P. aeruginosa

16
12
11

eAgNP-f
(CFU mL-1)
3596
8078
1987

Std
Dev
860
3621
868
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N
12
10
8

Ag+
(CFU mL-1)
3328
20051
1108

Std
Dev
911
10823
405

Figure S5. Depiction of the Na+ K+ pump where three Na+ ions are transported
out for every two K+ ions transported into the cell. Figure constructed courtesy of
ChemDoodle

41

Table S3. Statistical summary for OD600 values using a 95% confidence level
+

Ag : Time 1 - Time 0
Ag+: Time 2 - Time 0
Ag+: Time 4 - Time 0
Ag+: Time 24 - Time 0
eAgNP-f: Time 1 - Time 0
eAgNP-f: Time 2 - Time 0
eAgNP-f: Time 4 - Time 0
eAgNP-f: Time 24 - Time 0
Control: Time 1 - Time 0
Control: Time 2 - Time 0
Control: Time 4 - Time 0
Control: Time 24 - Time 0
Time 0: eAgNP-f - Ag+
Time 0: Control - Ag+
Time 0: Control - eAgNP-f
Time 1: eAgNP-f - Ag+
Time 1: Control - Ag+
Time 1: Control - eAgNP-f
Time 2: eAgNP-f - Ag+
Time 2: Control - Ag+
Time 2: Control - eAgNP-f
Time 4: eAgNP-f - Ag+
Time 4: Control - Ag+
Time 4: Control - eAgNP-f
Time 24: eAgNP-f - Ag+
Time 24: Control - Ag+
Time 24: Control - eAgNP-f

Standard Error
0.03214
0.05507
0.04986
0.08258
0.03214
0.05507
0.04986
0.08258
0.03214
0.05507
0.04986
0.08258
0.04288
0.04288
0.04288
0.04687
0.04687
0.04687
0.06708
0.06708
0.06708
0.05501
0.05501
0.05501
0.10880
0.10880
0.10880

42

DF
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24

Adj P
0.1008
0.0945
1.0000
<.0001
1.0000
1.0000
1.0000
1.0000
<.0001
0.0009
<.0001
<.0001
1.0000
1.0000
1.0000
0.2481
1.0000
0.0064
0.6791
1.0000
0.0459
1.0000
0.0129
0.0014
0.0063
1.0000
0.0055

Lower
Upper
0.02901 0.16170
0.05268 0.28000
-0.01458 0.19120
0.41890 0.75980
-0.1010 0.03166
-0.09498 0.13230
-0.07824 0.12760
-0.04943 0.29140
0.12730 0.26000
0.16200 0.38930
0.22080 0.42660
0.44860 0.78940
-0.07784 0.09917
-0.11050 0.06651
-0.12120 0.05584
-0.21610 -0.02261
-0.02039 0.17310
0.09894 0.29240
-0.27540 0.001439
-0.05111 0.22580
0.08589 0.36280
-0.16650 0.06053
0.09980 0.32690
0.15280 0.37990
-0.68230 -0.23310
-0.21690 0.23230
0.24070 0.68990

Table S4. Statistical summary for K+ concentration using a 95% confidence level.
+

Ag : Time 1 - Time 0
Ag+: Time 2 - Time 0
Ag+: Time 4 - Time 0
Ag+: Time 24 - Time 0
eAgNP-f: Time 1 - Time 0
eAgNP-f: Time 2 - Time 0
eAgNP-f: Time 4 - Time 0
eAgNP-f: Time 24 - Time 0
Control: Time 1 - Time 0
Control: Time 2 - Time 0
Control: Time 4 - Time 0
Control: Time 24 - Time 0
Time 0: eAgNP-f - Ag+
Time 0: Control - Ag+
Time 0: Control - eAgNP-f
Time 1: eAgNP-f - Ag+
Time 1: Control - Ag+
Time 1: Control - eAgNP-f
Time 2: eAgNP-f - Ag+
Time 2: Control - Ag+
Time 2: Control - eAgNP-f
Time 4: eAgNP-f - Ag+
Time 4: Control - Ag+
Time 4: Control - eAgNP-f
Time 24: eAgNP-f - Ag+
Time 24: Control - Ag+
Time 24: Control - eAgNP-f

Standard Error
0.02323

DF
24

Adj P
0.3844

Lower
Upper
-0.06853 0.02736

0.07302
0.05628
0.24350
0.02323
0.07302
0.05628
0.24350
0.02323
0.07302
0.05628
0.24350
0.04009
0.04009
0.04009
0.03943
0.03943
0.03943
0.10800
0.10800
0.10800
0.07978
0.07978
0.07978
0.34480
0.34480
0.34480

24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24

0.1599
0.0049
<.0001
0.3073
0.3627
0.3073
0.0476
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.0078
0.2717
<.0001

0.02174
0.10810
1.06850
-0.09031
-0.25120
-0.22020
0.21840
0.35520
0.73890
0.86740
1.44090
-0.52810
0.24240
0.68780
-0.54850
0.66740
1.13460
-0.94130
0.81940
1.53780
-0.93840
0.91970
1.69350
-2.00710
-0.01410
1.28140
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0.32310
0.34050
2.07360
0.00559
0.05018
0.01210
1.22350
0.45110
1.04030
1.09970
2.44600
-0.36270
0.40780
0.85320
-0.38580
0.83020
1.29740
-0.49550
1.26520
1.98360
-0.60910
1.24900
2.02280
-0.58390
1.40910
2.70460

